Skip to content

A Clinical Trial Study about Intermittent Fasting Combined with Energy-Restricted High-Protein Diet Is Superior to Traditional Intermittent Fasting in Weight Loss and Improvement of Cardiovascular Disease Risk Factors

A Clinical Trial Study about Intermittent Fasting Combined with Energy-Restricted High-Protein Diet Is Superior to Traditional Intermittent Fasting in Weight Loss and Improvement of Cardiovascular Disease Risk Factors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124778
Enrollment
Unknown
Registered
2026-05-18
Start date
2024-06-07
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight or obesity

Interventions

control group:Traditional intermittent fasting
Experimental group:Intermittent fasting combined with energy-restricted high-protein diets

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.According to the "Guidelines for the Prevention and Control of Overweight and Obesity in Chinese Adults" and the "Guidelines for Bariatric Surgery in China" :24kg/m^2<=BMI<=37.5 kg/m^2; 2.18y<=age<=65y; 3.The weight has remained stable in the past three months, with an increase or decrease of no more than 2 kilograms.

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women; 2.History of cancer-related diseases; 3.History of mental disorders such as claustrophobia and depression; 4.Have undergone weight loss surgery, are currently taking medications that may affect weight, and have been following a weight management plan for the past three months; 5.Patients with abnormal renal function and other conditions that are not suitable for a high-protein diet; 6.Patients with moderate to severe liver function impairment, such as those with transaminase levels exceeding 400U/L or presenting with jaundice, severe abdominal distension, fatigue, etc. 7.Gastrointestinal diseases and other factors affect intestinal absorption and transport. 8.Did not sign the informed consent form and was unwilling to participate in this researcher.

Design outcomes

Primary

MeasureTime frame
weight;

Secondary

MeasureTime frame
Muscle mass;Blood Pressure;Homocysteine;Heart rate;Insulin resistance index;high density lipoprotein cholesterol;total cholesterol;waist circumference;Small Dense Low-Density Lipoprotein Cholesterol;fasting blood-glucose;low density lipoprotein cholesterin;Visceral fat mass;Triglyceride;high density lipoprotein cholesterol;waist-to-hip ratio;Fasting Insulin;Free Fatty acid;hip circumference;Fat Mass;Creactiveprotein;

Countries

China

Contacts

Public ContactChenjiewen

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

jiewenchen963@126.com+86 21 53315416

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026